← Back to Search

Orthosis

Knee-Ankle-Foot Braces for Spinal Cord Injury

N/A
Waitlist Available
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Requires orthotic bracing for lower extremity instability, including the knee joint, unilaterally or bilaterally
Aged 18-80 years
Must not have
Cognitive impairments that limit study participation
Inability to stabilize the trunk with or without assistive devices (crutches, cane, etc.)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline in score after using device at 3, 6, and 12 month follow-up.
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two types of knee-ankle-foot braces to see which is more effective following discharge from inpatient rehab.

Who is the study for?
This trial is for adults aged 18-80 who are within 3-24 months post spinal cord injury. Participants must need lower extremity bracing, be able to charge and remember to wear devices daily, and weigh under 275 lbs. Those with unstable health conditions, severe spasticity, or significant leg length discrepancies cannot join.
What is being tested?
The study compares a microprocessor-controlled knee-ankle-foot orthosis (C-Brace II) with traditional care models in people after spinal cord injury rehab. It's randomized and measures how each orthosis affects the user over a three-month period at home.
What are the potential side effects?
While not explicitly stated, potential side effects may include discomfort from wearing the braces, skin issues where the brace contacts the body, and possible muscle or joint pain due to changes in movement patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need a brace for my leg or legs due to instability.
Select...
I am between 18 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have cognitive impairments that limit my participation.
Select...
I cannot keep my upper body stable, even with support like a cane.
Select...
My body weight is over 275 lbs.
Select...
My heart, brain, or cancer condition is stable.
Select...
My knee or hip cannot fully straighten, bending more than 10 degrees.
Select...
My legs differ in length by more than 6 inches.
Select...
I experience moderate to severe muscle stiffness.
Select...
I cannot use the C-Brace tool effectively to move my legs.
Select...
My knee bends inward or outward more than 10 degrees.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline in muscle strength after using device at 3, 6, and 12 month follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline in muscle strength after using device at 3, 6, and 12 month follow-up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Six Minute Walk Test (6MWT)
Secondary study objectives
10 Meter Walk Test (10MWT)
Berg Balance Scale (BBS)
Functional Gait Assessment (FGA)
+5 more
Other study objectives
Actigraph
Activities Specific Balance Confidence Scale (ABC)
EQ5D-5L
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: C-Brace II GroupExperimental Treatment1 Intervention
Subjects will be assigned a C-Brace II orthotic for use.
Group II: Traditional GroupActive Control1 Intervention
Subjects will continue with their own KAFO (non C-Brace II) use.

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
208 Previous Clinical Trials
17,895 Total Patients Enrolled
Otto Bock Healthcare Products GmbHIndustry Sponsor
15 Previous Clinical Trials
849 Total Patients Enrolled

Media Library

C-Brace II (Orthosis) Clinical Trial Eligibility Overview. Trial Name: NCT03930056 — N/A
Spinal Cord Injury Research Study Groups: C-Brace II Group, Traditional Group
Spinal Cord Injury Clinical Trial 2023: C-Brace II Highlights & Side Effects. Trial Name: NCT03930056 — N/A
C-Brace II (Orthosis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03930056 — N/A
~4 spots leftby Nov 2025